0001104659-23-108814.txt : 20231012 0001104659-23-108814.hdr.sgml : 20231012 20231012160540 ACCESSION NUMBER: 0001104659-23-108814 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231010 FILED AS OF DATE: 20231012 DATE AS OF CHANGE: 20231012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENTSUR RON CENTRAL INDEX KEY: 0001251213 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41264 FILM NUMBER: 231322785 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVE STREET 2: 20TH FL CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvectis Pharma, Inc. CENTRAL INDEX KEY: 0001875558 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862405608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 BUSINESS PHONE: 360-837-7232 MAIL ADDRESS: STREET 1: 1 BRIDGE PLAZA, SUITE 275 CITY: FORT LEE STATE: NJ ZIP: 07024 4 1 tm2328332-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-10-10 0 0001875558 Nuvectis Pharma, Inc. NVCT 0001251213 BENTSUR RON C/O NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 1 1 1 0 Chairman & CEO 0 Common Stock 2023-10-10 4 P 0 640 11.08 A 3237484 D Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.81 to $11.6243. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. Includes 426,759 shares of restricted stock. /s/ Ron Bentsur 2023-10-12